Exam (elaborations)
CMN 568 Unit 3 questions with complete solutions.
CMN 568 Unit 3 questions with complete solutions.CMN 568 Unit 3 questions with complete solutions.CMN 568 Unit 3 questions with complete solutions.CMN 568 Unit 3 questions with complete solutions.CMN 568 Unit 3 questions with complete solutions.CMN 568 Unit 3 questions with complete solutions.CMN 5...
[Show more]
Preview 3 out of 18 pages
Uploaded on
August 25, 2024
Number of pages
18
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
Institution
CMN 568
Course
CMN 568
$12.99
Also available in package deal from $30.49
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
$ 143.88
$ 30.49
12 items
1. Exam (elaborations) - Cmn 568- unit 1 study questions with complete solutions.
2. Exam (elaborations) - Cmn 568 - unit 2 questions with complete solutions.
3. Exam (elaborations) - Cmn 568 - unit 6 questions with complete solutions
4. Exam (elaborations) - Cmn 568 - unit 2 – all questions with complete solutions.
5. Exam (elaborations) - Cmn 568 final exam set – questions and answers.
6. Exam (elaborations) - Cmn 568 - unit 4 questions with complete solutions
7. Exam (elaborations) - Cmn 568 practice questions and answers.
8. Exam (elaborations) - Cmn 568 exam 1 questions with complete solutions.
9. Exam (elaborations) - Cmn 568 unit 3 questions with complete solutions.
10. Exam (elaborations) - Cmn 568 unit 3 questions with complete solutions.
11. Exam (elaborations) - Cmn 568 unit 3 questions with complete solutions.
12. Exam (elaborations) - Cmn 568 module 4 gi questions with complete solutions
Show more
CMN 568 Unit 3 questions with complete
solutions
What \are \the \3 \characteristics \of \Asthma \- \(correct \answer) \-Bronchoconstriction
Airway \Inflammation
Reversible \airflow \limitation
Which \inhaled \anticholinergic \is \best \used \for \asthma \pt. \w/an \intolerance \to \beta \agonist \or \
w/ \bronchospasms \due \to \beta \blocker \meds? \- \(correct \answer) \-Ipratropium \Bromide
What \is \the \primary \tx \for \pt. \w/moderate \to \severe \asthma \exacerbations \who \do \not \respond \
promptly \and \completely \to \SABA? \- \(correct \answer) \-Systemic \Corticosteroids
Which \bacterial \infections \predispose \exacerbations \of \asthma \- \(correct \answer) \-M. \
Pneumoniae \and \C. \Pneumoniae
Is \routine \use \of \antimicrobials \recommended \for \acute \exacerbations \of \asthma \- \(correct \
answer) \-No, \only \use \when \likelihood \of \acute \bacterial \respiratory \tract \infection
Name \short \acting \beta \agonist \- \(correct \answer) \-albuterol, \levalbuterol, \bitolerol, \pirbuterol, \
terbutaline
What \does \a \SABA \do? \- \(correct \answer) \-acts \directly \by \relaxing \bronchial \smooth \muscles.
What \do \long-term \pharmacologic \agents \accomplish \for \asthma \pt. \- \(correct \answer) \-act \
primarily \to \attenuate \airway \inflammation.
Why \take \long-term \pharmacologic \agents \for \asthma \daily? \- \(correct \answer) \-to \achieve \and \
maintain \control \of \persistent \asthma \independent \of \symptoms.
What \does \the \NAEPP \recommend \as \the \cornerstone \of \daily \treatment \of \persistent \
asthma? \- \(correct \answer) \-daily \anti-inflammatory \therapy \with \inhaled \corticosteroids
Role \of \corticosteroids \with \asthma \- \(correct \answer) \-Reduce \inflammation \(acute \and \chronic) \
= \improved \airflow, \decreased \airway \hyper-responsiveness \and \fewer \asthma \exacerbations, \and \
potentiate \the \action \of \beta-adrenergic \agonist.
,1st. \line \treatment \agent \for \all \pt \w/persistent \asthma \(long \term \controller) \- \(correct \
answer) \-Inhaled \Corticosteroids
How \often \to \most \patient \use \inhaled \corticosteroids? \- \(correct \answer) \-Twice \daily \to \
provide \adequate \control.
How \long \can \it \take \to \see \maximum \response \of \inhaled \corticosterioids? \- \(correct \answer) \-
Months
What \can \a \patient \do \to \reduce \side \effects \of \inhaled \corticosteroids? \- \(correct \answer) \-Rinse
\mouth \after \each \use
A \patient \has \an \exacerbation \of \asthma, \what \is \the \most \effective \treatment \to \achieve \
prompt \control? \- \(correct \answer) \-Systemic \(oral) \corticosteroids
Dose \of \oral \corticosteroids \for \children \during \exacerbation \of \asthma \- \(correct \answer) \-1-2 \
mg/kg/day. \
Can \be \either \a \single \dose \or \divided \BID. \
MAX \60 \mg/day
Dose \of \oral \corticosteroids \for \adults \during \exacerbation \of \asthma \- \(correct \answer) \-40-60 \
mg/day
either \as \a \single \dose \of \divided \BID
Duration \of \treatment \of \oral \corticosteroids \for \asthma \exacerbation \- \(correct \answer) \-3-10 \
days \or \until \symptoms \resolve \
(no \evidence \that \tapering \dose \of \PO \steroids \prevents \relapse)
When \treating \exacerbation \of \asthma, \what \is \the \preferred \treatment \plan? \- \(correct \
answer) \-Alternate \days \rather \than \daily \treatment.
What \additional \medications \are \required \to \be \given \concurrent \with \systemic \corticosteroids \
to \prevent \corticosteroid \induced \bone \mineral \loss? \- \(correct \answer) \-Vitamin \D \and \Calcium
Should \systemic \corticosteroids \be \rapidly \discontinued? \- \(correct \answer) \-No, \to \prevent \
adrenal \insufficiency
Name \some \mediator \inhibitors \to \treat \asthma \- \(correct \answer) \-Cromolyn \sodium \and \
nedocromil
What \is \the \mechanism \of \action \of \mediator \inhibitors? \- \(correct \answer) \-prevent \asthma \
symptoms, \improve \airway \function \in \pt \w/mild \persistent \of \exercise \induce \asthma
When \are \mediator \inhibitors \effective? \- \(correct \answer) \-Before \allergen \exposure \or \exercise
, Do \not \relieve \asthmatic \symptoms \once \present.
Name \the \Long \acting \beta \2 \agonist \(LABA) \for \asthma \- \(correct \answer) \-Salmeterol \and \
Formoteol
How \are \LABA's \delivered? \- \(correct \answer) \-dry \powder
What \are \LABA's \used \for \- \(correct \answer) \-Long \term \prevention \of \asthma \symptoms
Nocturnal \symptoms
Prevention \of \exercise \induced \bronchospasm
Should \LABA \be \used \as \monotherapy \- \(correct \answer) \-NO
linked \to \fatal \asthma \when \used \alone
has \no \anti-inflammatory \effects- \so \use \w/a \corticosteroid.
What \does \LABA \+ \low \or \medium \dose \of \corticosteroids \given \together \provide \for \the \
patient. \- \(correct \answer) \-The \equivalent \to \what \would \be \if \doubled \the \inhaled \
corticosteroid.
Name \the \action \of \anticholinergic \agents, \short \acting \muscarinic \agents \(SAMA) \and \long \
acting \muscarinic \agents \(LAMA) \- \(correct \answer) \-Reverse \vagally \medicated \bronchospasm \
but \NOT \allergen \or \exercise \induced \broncospasms
Is \Ipratropium \bromide \(SAMA) \as \effect \as \a \SABA \for \relief \of \acute \bronchospasm \- \(correct \
answer) \-No
What \is \the \benefit \to \adding \Tiotropium \to \therapy \bronchodilator \(salmeterol) \or \inadequately \
controlled \low-dose \inhaler. \- \(correct \answer) \-Improves \lung \function \and \reduces \frequency \of \
asthma \exacerbations.
Name \the \phosphodiesterase \inhibitor \used \for \asthma \- \(correct \answer) \-theophylline
What \is \theophylline \used \for \in \a \pt \w/ \asthma? \- \(correct \answer) \-mild \bronchodilation
What \is \the \mechanism \of \action \of \theophylline \for \asthma \- \(correct \answer) \-anti-
inflammatory \and \immunodilator \properties \which \enhance \mucociliary \clearance \and \strengthen \
diaphragmatic \contractility.
Why \are \drug \levels \of \Theophylline \monitored? \- \(correct \answer) \-Due \to \narrow \therapeutic \
ranges.
Name \the \leukotriene \modifiers \for \asthma \- \(correct \answer) \-Zileutonn, \zafirlukast, \montelukast